Wikidata entity: Q412515
C₁₈H₃₁NO₄ (P274)
Quantities
| P4250 | defined daily dose | 10 |
| P2067 | mass | 325.225308 |
| P233 | canonical SMILES | String | CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O | ??? |
| P373 | Commons category | String | Bisoprolol | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q12152 (myocardial infarction) | myocardial infarction |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q180762 (angina pectoris) | angina pectoris |
| P2175 | medical condition treated | ... | Q19000661 (congestive heart failure) | congestive heart failure |
| P2175 | medical condition treated | ... | Q1598909 (supraventricular tachycardia) | supraventricular tachycardia |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q280786 (terazosin) | terazosin |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411887 (rivastigmine) | rivastigmine |
| P769 | significant drug interaction | ... | Q419939 (doxazosin) | doxazosin |
| P769 | significant drug interaction | ... | Q419944 (moxonidine) | moxonidine |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q412621 (methyldopa) | methyldopa |
| P769 | significant drug interaction | ... | Q418480 (tamsulosin) | tamsulosin |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q425296 (prazosin) | prazosin |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q2736873 (alfuzosin) | alfuzosin |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q50430373 (Adrenergic beta-1 Receptor Antagonists) | Adrenergic beta-1 Receptor Antagonists |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q816759 (beta blocker) | beta blocker |
| P2868 | subject has role | ... | Q1752522 (Sympatholytic) | Sympatholytic |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | bisoprolol | ??? |
Why not click here or view trends?
log id: 2585537